Follow the people · Insider
Fran Schulz
Fran Schulz files insider transactions with the SEC as a director of Edap Tms Sa (FOCL). We hold 1 disclosed purchase or sale filed since 10 December 2024, 1 of them in the last 90 days.
- Files forFOCL
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure17 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 14 August 2026 — 14 August 2026Director · Edap Tms Sa (FOCL)1 Form 4 line · source: SEC Form 4
- Filed 9 December 2024 — 25 June 2025Director · Senti Biosciences (SNTI)3 Form 4 lines · source: SEC Form 4
Everything they disclosed
4 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 10,000 shares of Edap Tms SaSEC Form 417 August 2026Common Stock · traded 14 August 2026 · filed 17 August 2026
- was granted 21,950 shares of Senti Biosciences (a derivative holding)SEC Form 427 June 2025Stock Option (Right to Buy) · traded 25 June 2025 · filed 27 June 2025
- was granted 43,900 shares of Senti Biosciences (a derivative holding)SEC Form 411 March 2025Stock Option (Right to Buy) · traded 7 March 2025 · filed 11 March 2025
- was granted 12,500 shares of Senti Biosciences (a derivative holding)SEC Form 410 December 2024Stock Option (Right to Buy) · traded 9 December 2024 · filed 10 December 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.